Stock price performance of IDEXX Laboratories, Inc. is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 30.09% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 27.75% . Looking at the past 52 week period, the stock price is up at 99.92% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of IDEXX Laboratories, Inc. has a positive value of 49.73 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 2.3% and the 50-Day Moving Average is 2.91%.The 200 Day SMA reached 16.89%
Based on the Stock Research IDEXX Laboratories, Inc. Relative Strength Index signal is in over bought territory with a range of 83.05. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has climbed 16.74% in the past week and advanced 19.99% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 16.6% and the outperformance has advanced to 18.92% for the last 4 weeks period.
Company has reported several Insider transactions to the SEC, on Nov 30, 2016, Jonathan W Ayers (Chairman, President & CEO) sold 27,424 shares at 119.77 per share price.On Nov 28, 2016, Thomas Craig (director) sold 8,500 shares at 120.06 per share price.On Nov 9, 2016, William T End (director) sold 5,000 shares at 109.87 per share price.
IDEXX Laboratories Last issued its quarterly earnings results on Feb 2, 2017. The company reported $0.58 EPS for the quarter, beating the analyst consensus estimate by $ 0.07. Analyst had a consensus of $0.51. The company had revenue of $443.00 million for the quarter, compared to analysts expectations of $436.07 million. The companys revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.48 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.IDEXX Laboratories was Downgraded by Feltl & Co. to Sell on Feb 3, 2017.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) : On Friday heightened volatility was witnessed in IDEXX Laboratories, Inc. (NASDAQ:IDXX) which led to swings in the share price. The stock opened for trading at $139.53 and hit $142.86 on the upside , eventually ending the session at $142.02, with a gain of 2.12% or 2.95 points. The heightened volatility saw the trading volume jump to 1,758,148 shares. The 52-week high of the share price is $142.86 and the company has a market cap of $12,733 million. The 52-week low of the share price is at $66.82 .
IDEXX Laboratories, Inc. is a world leader in providing diagnostic, detection, and information products to the animal health industry as well as quality assurance products and services to the food and water industries.